Biolyse Pharma Corp.

The Centers for Medicare and Medicaid Services could authorize lower-cost generic versions of Astellas Pharma and Pfizer ’s prostate cancer drug Xtandi in government-sponsored insurance programs us

The Centers for Medicare and Medicaid Services could authorize lower-cost generic versions of Astellas Pharma US Inc. and Pfizer Inc. ’s prostate cancer drug Xtandi in government-sponsored insuranc

After striking out with previous administrations, petitioners backed by Knowledge Ecology International are once again asking the Department of Health and Human Services to grant march-in rights to Xt